組換えタンパク質の市場規模は、2022年に27億5,000万ドルと評価され、2023年の29 億 7,000 万ドルから 2032 年までに 54 億 9,000 万ドルに成長し、予測期間 (2024 年から 2032 年) の間に 8.00% のCAGRを示すと予測されます。研究開発への医療機関による投資の増加、慢性疾患の有病率の上昇、ウイルス感染の減少に焦点を当てた規制機関の急増が、組換えタンパク質市場の重要な市場推進要因になると予想されます。
目次
TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. GLOBAL RECOMBINANT PROTEINS MARKET, BY PRODUCT
6.1. Overview
6.2. Hormones
6.3. Growth Factors
6.4. Antibody
6.5. Enzymes
6.6. Other Types of Products
7. GLOBAL RECOMBINANT PROTEINS MARKET, BY APPLICATION
7.1. Overview
7.2. Research Applications
7.3. Therapeutic Use
7.4. Biotechnology Industry
8. GLOBAL RECOMBINANT PROTEINS MARKET, BY REGION
8.1. Overview
8.1. North America
8.1.1. US
8.1.2. Canada
8.2. Europe
8.2.1. Germany
8.2.2. France
8.2.3. UK
8.2.4. Italy
8.2.5. Spain
8.2.6. Rest of Europe
8.3. Asia-Pacific
8.3.1. China
8.3.2. India
8.3.3. Japan
8.3.4. South Korea
8.3.5. Australia
8.3.6. Rest of Asia-Pacific
8.4. Rest of the World
8.4.1. Middle East
8.4.2. Africa
8.4.3. Latin America
9. COMPETITIVE LANDSCAPE
9.1. Overview
9.2. Competitive Analysis
9.3. Market Share Analysis
9.4. Major Growth Strategy in the Global Recombinant Proteins Market,
9.5. Competitive Benchmarking
9.6. Leading Players in Terms of Number of Developments in the Global Recombinant Proteins Market,
9.7. Key developments and Growth Strategies
9.7.1. New Product Launch/Service Deployment
9.7.2. Merger & Acquisitions
9.7.3. Joint Ventures
9.8. Major Players Financial Matrix
9.8.1. Sales & Operating Income, 2023
9.8.2. Major Players R&D Expenditure. 2023
10. COMPANY PROFILES
10.1. Abbvie Inc
10.1.1. Company Overview
10.1.2. Financial Overview
10.1.3. Products Offered
10.1.4. Key Developments
10.1.5. SWOT Analysis
10.1.6. Key Strategies
10.2. AMGEN INC
10.2.1. Company Overview
10.2.2. Financial Overview
10.2.3. Products Offered
10.2.4. Key Developments
10.2.5. SWOT Analysis
10.2.6. Key Strategies
10.3. Bio-Rad Laboratories Inc
10.3.1. Company Overview
10.3.2. Financial Overview
10.3.3. Products Offered
10.3.4. Key Developments
10.3.5. SWOT Analysis
10.3.6. Key Strategies
10.4. Eli Lilly and Company.
10.4.1. Company Overview
10.4.2. Financial Overview
10.4.3. Products Offered
10.4.4. Key Developments
10.4.5. SWOT Analysis
10.4.6. Key Strategies
10.5. Merck KGaA
10.5.1. Company Overview
10.5.2. Financial Overview
10.5.3. Products Offered
10.5.4. Key Developments
10.5.5. SWOT Analysis
10.5.6. Key Strategies
10.6. NOVO NORDISK AS
10.6.1. Company Overview
10.6.2. Financial Overview
10.6.3. Products Offered
10.6.4. Key Developments
10.6.5. SWOT Analysis
10.6.6. Key Strategies
10.7. Sanofi SA
10.7.1. Company Overview
10.7.2. Financial Overview
10.7.3. Products Offered
10.7.4. Key Developments
10.7.5. SWOT Analysis
10.7.6. Key Strategies
10.8. THERMO FISHER SCIENTIFIC INC
10.8.1. Company Overview
10.8.2. Financial Overview
10.8.3. Products Offered
10.8.4. Key Developments
10.8.5. SWOT Analysis
10.8.6. Key Strategies
10.9. Novartis AG
10.9.1. Company Overview
10.9.2. Financial Overview
10.9.3. Products Offered
10.9.4. Key Developments
10.9.5. SWOT Analysis
10.9.6. Key Strategies
10.10. GLAXOSMITHKLINE PLC
10.10.1. Company Overview
10.10.2. Financial Overview
10.10.3. Products Offered
10.10.4. Key Developments
10.10.5. SWOT Analysis
10.10.6. Key Strategies
11. APPENDIX
11.1. References
11.2. Related Reports
LIST OF TABLES
TABLE 1 GLOBAL RECOMBINANT PROTEINS MARKET, SYNOPSIS, 2019-2032
TABLE 2 GLOBAL RECOMBINANT PROTEINS MARKET, ESTIMATES & FORECAST, 2019-2032 (USD BILLION)
TABLE 3 GLOBAL RECOMBINANT PROTEINS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 4 GLOBAL RECOMBINANT PROTEINS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 5 NORTH AMERICA: RECOMBINANT PROTEINS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 6 NORTH AMERICA: RECOMBINANT PROTEINS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 7 US: RECOMBINANT PROTEINS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 8 US: RECOMBINANT PROTEINS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 9 CANADA: RECOMBINANT PROTEINS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 10 CANADA: RECOMBINANT PROTEINS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 11 EUROPE: RECOMBINANT PROTEINS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 12 EUROPE: RECOMBINANT PROTEINS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 13 GERMANY: RECOMBINANT PROTEINS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 14 GERMANY: RECOMBINANT PROTEINS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 15 FRANCE: RECOMBINANT PROTEINS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 16 FRANCE: RECOMBINANT PROTEINS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 17 ITALY: RECOMBINANT PROTEINS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 18 ITALY: RECOMBINANT PROTEINS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 19 SPAIN: RECOMBINANT PROTEINS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 20 SPAIN: RECOMBINANT PROTEINS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 21 UK: RECOMBINANT PROTEINS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 22 UK: RECOMBINANT PROTEINS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 23 REST OF EUROPE: RECOMBINANT PROTEINS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 24 REST OF EUROPE: RECOMBINANT PROTEINS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 25 ASIA-PACIFIC: RECOMBINANT PROTEINS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 26 ASIA-PACIFIC: RECOMBINANT PROTEINS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 27 JAPAN: RECOMBINANT PROTEINS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 28 JAPAN: RECOMBINANT PROTEINS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 29 CHINA: RECOMBINANT PROTEINS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 30 CHINA: RECOMBINANT PROTEINS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 31 INDIA: RECOMBINANT PROTEINS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 32 INDIA: RECOMBINANT PROTEINS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 33 AUSTRALIA: RECOMBINANT PROTEINS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 34 AUSTRALIA: RECOMBINANT PROTEINS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 35 SOUTH KOREA: RECOMBINANT PROTEINS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 36 SOUTH KOREA: RECOMBINANT PROTEINS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 37 REST OF ASIA-PACIFIC: RECOMBINANT PROTEINS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 38 REST OF ASIA-PACIFIC: RECOMBINANT PROTEINS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 39 REST OF THE WORLD: RECOMBINANT PROTEINS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 40 REST OF THE WORLD: RECOMBINANT PROTEINS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 41 MIDDLE EAST: RECOMBINANT PROTEINS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 42 MIDDLE EAST: RECOMBINANT PROTEINS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 43 AFRICA: RECOMBINANT PROTEINS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 44 AFRICA: RECOMBINANT PROTEINS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 45 LATIN AMERICA: RECOMBINANT PROTEINS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 46 LATIN AMERICA: RECOMBINANT PROTEINS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL RECOMBINANT PROTEINS MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL RECOMBINANT PROTEINS MARKET
FIGURE 4 GLOBAL RECOMBINANT PROTEINS MARKET, SHARE (%), BY PRODUCT, 2023
FIGURE 5 GLOBAL RECOMBINANT PROTEINS MARKET, SHARE (%), BY APPLICATION, 2023
FIGURE 6 GLOBAL RECOMBINANT PROTEINS MARKET, SHARE (%), BY REGION, 2023
FIGURE 7 NORTH AMERICA: RECOMBINANT PROTEINS MARKET, SHARE (%), BY REGION, 2023
FIGURE 8 EUROPE: RECOMBINANT PROTEINS MARKET, SHARE (%), BY REGION, 2023
FIGURE 9 ASIA-PACIFIC: RECOMBINANT PROTEINS MARKET, SHARE (%), BY REGION, 2023
FIGURE 10 REST OF THE WORLD: RECOMBINANT PROTEINS MARKET, SHARE (%), BY REGION, 2023
FIGURE 11 GLOBAL RECOMBINANT PROTEINS MARKET: COMPANY SHARE ANALYSIS, 2023 (%)
FIGURE 12 ABBVIE INC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 13 ABBVIE INC: SWOT ANALYSIS
FIGURE 14 AMGEN INC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 15 AMGEN INC: SWOT ANALYSIS
FIGURE 16 BIO-RAD LABORATORIES INC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 17 BIO-RAD LABORATORIES INC: SWOT ANALYSIS
FIGURE 18 ELI LILLY AND COMPANY: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 19 ELI LILLY AND COMPANY: SWOT ANALYSIS
FIGURE 20 MERCK KGAA: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 21 MERCK KGAA: SWOT ANALYSIS
FIGURE 22 NOVO NORDISK AS: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 23 NOVO NORDISK AS: SWOT ANALYSIS
FIGURE 24 SANOFI SA. : FINANCIAL OVERVIEW SNAPSHOT
FIGURE 25 SANOFI SA. : SWOT ANALYSIS
FIGURE 26 THERMO FISHER SCIENTIFIC INC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 27 THERMO FISHER SCIENTIFIC INC: SWOT ANALYSIS
FIGURE 28 NOVARTIS AG: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 29 NOVARTIS AG: SWOT ANALYSIS
FIGURE 30 GLAXOSMITHKLINE PLC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 31 GLAXOSMITHKLINE PLC: SWOT ANALYSIS
